1st Global Advisors’s Haemonetics HAE Stock Holding History

1st Global Advisors’s Portfolio HAE Stock Details HAE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-8,155	Closed	-$366K	–	473
2015 Q1	$366K	Buy	8,155 +189	+2%	+$7.9K	0.05%	281
2014 Q4	$298K	Buy	7,966 +544	+7%	+$19.9K	0.04%	322
2014 Q3	$259K	Buy	7,422 +1,553	+26%	+$55.4K	0.04%	347
2014 Q2	$207K	Buy	+5,869	New	+$196K	0.03%	417
2014 Q1	–	Sell	-6,809	Closed	-$287K	–	412
2013 Q4	$287K	Sell	6,809 -136	-2%	-$5.6K	0.05%	280
2013 Q3	$277K	Buy	6,945 +13	+0.2%	+$545	0.06%	265
2013 Q2	$287K	Buy	+6,932	New	+$281K	0.06%	244

Other funds holding HAE

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

WHG

Westwood Holdings Group Dallas, Texas $13.7B AUM 21.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

1st Global Advisors's HAE Position: Q2 2015 in Review

1st Global Advisors sold out of Haemonetics (HAE) in Q2 2015, closing a stake of 8,155 shares — an estimated $366K sold.

1st Global Advisors first reported a position in HAE in Q2 2013 and held it in 7 quarters. The position peaked at $366K in Q1 2015. 180 funds tracked by Wall St. Rank hold HAE as of Q2 2015.

1st Global Advisors reported no remaining Haemonetics position as of Q2 2015 after selling out during the quarter.
1st Global Advisors sold 8,155 Haemonetics shares in Q2 2015, an estimated $366K.
1st Global Advisors first reported a position in Haemonetics in Q2 2013 and held it in 7 quarters.
1st Global Advisors's Haemonetics position peaked at $366K in Q1 2015.
180 funds tracked by Wall St. Rank held Haemonetics as of Q2 2015.

Based on 1st Global Advisors's 13F filing for Q2 2015, filed 15 Jul 2015.